Dr Stefano Vella
NEAT ID Committee Membership:
Communications and External (Chair)
Data Studies (Vice Chair)
Associate Professor, Global Health, Catholic University of Rome. Coordinator, Centre for
Global Health, Catholic University of Rome. Senior Advisor, Global Access to Medicines.
Associate Professor, Clinical Trials Methodology, University of Tor Vergata, Rome. Member,
Antiretroviral Strategies Transformative Science Panel, AIDS Clinical Trial Group (ACTG),
National Institutes of Health (NIH), USA.
Previously held positions:
Director, National Center for Global Health, Istituto Superiore di Sanità (the Italian National Institute of Health), Rome (2017-2019). President, Italian Medicines Agency (AIFA) (2017-2018). Director, Department of Pharmacology, Istituto Superiore di Sanità (2003 -2016)
Stefano Vella received his degree in Medicine from the University of Rome in 1977. He subsequently achieved specialty degrees in both Infectious Diseases (1982) and Internal Medicine (1987). After a postdoctoral experience at the University of Pennsylvania (1981-1982), he joined the medical staff at the Institute of Internal Medicine, University La Sapienza, Rome, where he developed extensive experience in the clinical management of internal medicine and infectious diseases patients. In 1992, he was appointed Research Director of HIV/AIDS at the Istituto Superiore di Sanità (ISS), the Italian National Institute of Health. Specific work has been conducted by Dr Vella and his research group on the clinical development of antiretroviral therapy.
Since 1996, as Member of the Governing Council of the International AIDS Society (IAS) and subsequently as IAS President (2000-2002), he actively worked towards promoting access to treatment and care in the South of the World. He was instrumental for the organisation of the AIDS Conference in Durban, South Africa (2000).
He has been a member (2004-2007) of the Scientific Advice Working Group (SAWG) of the European Medicines Agency (EMA), London and has served as Vice President of the Scientific Council, ANRS (Agence Nationale de Recherche sur le Sida), Paris, France (2015-2018). In 2013, he chaired the Panel who developed the WHO Guidelines on HIV Treatment and Care and was member of the panel who revised the guidelines in 2016 and has been a Member of Technical Review Panel (TRP) of the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), 2003-2004. He subsequently served as the Italian representative in the GFTAM Board (2006-2007).
From 2006 till 2013 he chaired the NEAT ID Foundation funded by the European Commission, involving 40 European partner institutions from 16 countries.